Safety and Efficacy of an Amniotic Suspension Allograft Injection for Symptomatic Knee OA
How to Cite
OrthoEvidence. Safety and Efficacy of an Amniotic Suspension Allograft Injection for Symptomatic Knee OA. ACE Report. 2021;79(1):1. Available from: https://myorthoevidence.com/AceReport/Report/13822
Safety and Efficacy of an Amniotic Suspension Allograft Injection Over 12 Months in a Single-Blinded, Randomized Controlled Trial for Symptomatic Osteoarthritis of the Knee.Arthroscopy. 2021 Jul;37(7): 2246-2257.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Two-hundred patients with moderate, symptomatic knee osteoarthritis were randomized to receive an intra-articular injection of amniotic suspension allograft (ASA; n=68), hyaluronic acid (HA; n=64) or normal saline (n=68). Outcomes of interest included the change from baseline at 12 months in the Knee Injury and Osteoarthritis Outcome Score (KOOS) subsets (pain; symptoms; activities of daily living...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE